Cook R, Blalock K, El Ibrahimi S, Hoffman K, Levander X, Little K
J Gen Intern Med. 2025; .
PMID: 40000522
DOI: 10.1007/s11606-025-09444-3.
Ahluwalia T, Xu X, Nelson A, Gujral I, Okafor J, Hubbard M
Cureus. 2025; 16(12):e75395.
PMID: 39781180
PMC: 11709703.
DOI: 10.7759/cureus.75395.
Laing R, Donnelly C
PLoS One. 2024; 19(7):e0306395.
PMID: 38980856
PMC: 11233025.
DOI: 10.1371/journal.pone.0306395.
Daniels S, Cave S, Wagner T, Perez T, Edmond S, Becker W
Health Serv Res. 2024; 59 Suppl 2:e14345.
PMID: 38956400
PMC: 11540574.
DOI: 10.1111/1475-6773.14345.
Zahan R, Osgood N, Plouffe R, Orpana H
Int J Environ Res Public Health. 2024; 21(4).
PMID: 38673354
PMC: 11050073.
DOI: 10.3390/ijerph21040442.
Primary Care Providers' Experiences Treating Opioid Use Disorder Using Telehealth in the Height of the COVID-19 Pandemic.
Marshall S, Siebenmorgen L, Youngen K, Borders T, Zaller N
J Prim Care Community Health. 2024; 15():21501319241246359.
PMID: 38600789
PMC: 11008087.
DOI: 10.1177/21501319241246359.
The Relationship Between Workplace Drug Policies, Opioid Misuse, and Psychological Distress: Evidence From the 2020 National Survey on Drug Use and Health.
Le A, Urban-Wojcik E, Seewald M, Mezuk B
New Solut. 2024; 34(1):22-37.
PMID: 38332622
PMC: 11003197.
DOI: 10.1177/10482911241231523.
Identifying Patient Characteristics Associated With Opioid Use to Inform Surgical Pain Management.
Agarwal A, Xiong R, Ebert J, Shofer F, Spencer E, Lee D
Ann Surg Open. 2023; 4(4):e355.
PMID: 38144506
PMC: 10735081.
DOI: 10.1097/AS9.0000000000000355.
Effects of Buprenorphine, Methadone and Substance-Use on COVID-19 Morbidity and Mortality.
Christian N, Zhou X, Radhakrishnan R
medRxiv. 2023; .
PMID: 38077025
PMC: 10705636.
DOI: 10.1101/2023.11.24.23298995.
Physician perspectives on chronic pain management: barriers and the use of eHealth in the COVID-19 era.
Kaseweter K, Nazemi M, Gregoire N, Louw W, Walsh Z, Holtzman S
BMC Health Serv Res. 2023; 23(1):1131.
PMID: 37864210
PMC: 10588239.
DOI: 10.1186/s12913-023-10157-8.
Mental health and substance use disorder comorbidities among Medicaid beneficiaries: Associations with opioid use disorder and prescription opioid misuse.
Swartz J, Franceschini D, Scamperle K
AIMS Public Health. 2023; 10(3):658-677.
PMID: 37842281
PMC: 10567978.
DOI: 10.3934/publichealth.2023046.
Methamphetamine use and illicit opioid use during buprenorphine treatment.
Kratina-Hathaway Z, Radick A, Leroux B, Blalock K, Kim T, Darnton J
J Subst Use Addict Treat. 2023; 151.
PMID: 37811395
PMC: 10554569.
DOI: 10.1016/j.josat.2022.208934.
Integrating Text Messaging in a Low Threshold Telebuprenorphine Program for New York City Residents with Opioid Use Disorder during COVID-19: A Pilot Randomized Controlled Trial.
Tofighi B, Badiei B, Badolato R, Lewis C, Nunes E, Thomas A
J Addict Med. 2023; 17(5):e281-e286.
PMID: 37788603
PMC: 10544683.
DOI: 10.1097/ADM.0000000000001161.
Association of Medication-Assisted Therapy and Risk of Drug Overdose-Related Hospitalization or Emergency Room Visits in Patients With Opioid Use Disorder.
Bahrami K, Kuo Y, Digbeu B, Raji M
Cureus. 2023; 15(8):e44167.
PMID: 37753052
PMC: 10519365.
DOI: 10.7759/cureus.44167.
Interrupted time series analysis of drug overdose fatalities in service-related industries versus non-service-related industries during the COVID-19 pandemic, 2018-2021.
Bunn T, Costich J, Mirzaian M, Daniels L, Wang D, Quesinberry D
Inj Prev. 2023; 29(6):511-518.
PMID: 37648420
PMC: 10715517.
DOI: 10.1136/ip-2023-044894.
Prevalence and Correlates of Opioid-Involved Suicides in Maryland.
Susukida R, Nestadt P, Kharrazi H, Wilcox H
Arch Suicide Res. 2023; 28(2):660-673.
PMID: 37143364
PMC: 10624645.
DOI: 10.1080/13811118.2023.2207612.
Rates and Correlates of Alcohol and Substance Use Among Women Veterans During the COVID-19 Pandemic: The Moderating Role of COVID-Specific Anxiety.
Buckheit K, Pengelly C, Ramon A, Guyker W, Cook-Cottone C, King Jr P
Womens Health Issues. 2023; 33(3):250-257.
PMID: 37003919
PMC: 9977618.
DOI: 10.1016/j.whi.2023.02.001.
COVID-19-Related Changes to Drug-Selling Networks and Their Effects on People Who Use Illicit Opioids.
Frank D, Krawczyk N, Arshonsky J, Bragg M, Friedman S, Bunting A
J Stud Alcohol Drugs. 2023; 84(2):222-229.
PMID: 36971722
PMC: 10171252.
DOI: 10.15288/jsad.21-00438.
The Association of Opioid Use Disorder and COVID-19, a Longitudinal Study.
Jamali Z, Emamian M, Hashemi H, Fotouhi A
Int J Prev Med. 2023; 13:157.
PMID: 36910999
PMC: 9999101.
DOI: 10.4103/ijpvm.ijpvm_68_22.
Patient experiences of methadone treatment changes during the first wave of COVID-19: a national community-driven survey.
Brothers S, Palayew A, Simon C, Coulter A, Strichartz K, Voyles N
Harm Reduct J. 2023; 20(1):31.
PMID: 36894968
PMC: 9996563.
DOI: 10.1186/s12954-023-00756-3.
